Skip to main content
Atrás
Watch Compare

Editas Medicine, Inc.

Calidad de datos: 100%
EDIT
Nasdaq Manufacturing Chemicals
$2.89
▲ $0.13 (4.53%)
Cap. Mercado: 282.36 M
Precio
$2.89
Cap. Mercado
282.36 M
Rango del Día
$2.72 — $2.92
Rango de 52 Semanas
$1.04 — $4.54
Volumen
998,381
Apertura $2.75
Promedio 50D / 200D
$2.15
34.25% above
Promedio 50D / 200D
$2.59
11.35% above

Quick Summary

Puntos Clave

Revenue grew 12.23% annually over 5 years — strong growth
Debt/Equity of 4.02 — high leverage
Negative free cash flow of -165.85 M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 13.16%
Capital efficient — spends only 1.50% of revenue on capex

Crecimiento

Revenue Growth (5Y)
12.23%
Above sector avg (9.35%)
Revenue (1Y)25.39%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Calidad

Return on Equity
-980.70%
Below sector avg (-51.02%)
ROIC-88.83%
Net Margin-395.01%
Op. Margin-394.89%

Seguridad

Debt / Equity
4.02
Above sector avg (0.33)
Current Ratio2.86
Interest Coverage-25.93

Valoración

PE (TTM)
-1.76
Above sector avg (-1.98)
P/B Ratio20.99
EV/EBITDAN/A
Dividend YieldN/A

Historial de Precios

Tendencias Financieras

Comparación con Pares

vs mediana del sector Manufacturing (44 pares)
Métrica Acción Mediana del Sector
P/E -1.8 -2.0
P/B 21.0 5.1
ROE % -980.7 -51.0
Net Margin % -395.0 -150.2
Rev Growth 5Y % 12.2 9.3
D/E 4.0 0.3

ETFs Holding This Stock

MEDX logo MEDX Horizon Kinetics Medical ETF
0.61% weight
NXTE logo NXTE AXS Green Alpha ETF
0.31% weight
GSSC logo GSSC Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF
0.03% weight
IWV logo IWV iShares Russell 3000 ETF
0.00% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) 25.39% Revenue Growth (3Y) -27.98%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 12.23% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 40.52 M Net Income (TTM) -160.06 M
ROE -980.70% ROA -77.64%
Gross Margin N/A Operating Margin -394.89%
Net Margin -395.01% Free Cash Flow (TTM) -165.85 M
ROIC -88.83% FCF Growth (3Y) N/A
Safety
Debt / Equity 4.02 Current Ratio 2.86
Interest Coverage -25.93 Asset Turnover 0.20
Working Capital 115.12 M Tangible Book Value 13.45 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -1.76 Forward P/E N/A
P/B Ratio 20.99 P/S Ratio 6.97
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -58.74%
Market Cap 282.36 M Enterprise Value 170.78 M
Per Share
EPS (Diluted TTM) -1.80 Revenue / Share 0.41
FCF / Share -1.69 OCF / Share -1.69
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 1.50% FCF Conversion 103.62%
SBC-Adj. FCF -178.52 M Growth Momentum 13.16

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 40.52 M 32.31 M 78.12 M 19.71 M 25.54 M
Net Income -160.06 M -237.09 M -153.22 M -220.43 M -192.50 M
EPS (Diluted) -1.80 -2.88 -2.02 -3.21 -2.83
Gross Profit — — — — —
Operating Income -160.01 M -251.15 M -169.18 M -225.95 M -193.15 M
EBITDA — — — — —
R&D Expenses 89.95 M 199.25 M 177.65 M 174.96 M 142.51 M
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense 6.17 M 2.13 M — — —
Income Tax 0.0 0.0 0.0 0.0 —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 186.53 M 341.59 M 499.15 M 514.32 M 677.48 M
Total Liabilities 159.25 M 207.32 M 150.06 M 153.64 M 123.84 M
Shareholders' Equity 27.29 M 134.27 M 349.10 M 360.68 M 553.64 M
Total Debt 53.61 M 57.43 M — — —
Cash & Equivalents 146.65 M 131.54 M 123.65 M 141.52 M 203.52 M
Current Assets 163.90 M 289.32 M 340.83 M 356.75 M 507.31 M
Current Liabilities 46.25 M 77.23 M 63.22 M 60.11 M 46.88 M